Home About Us News Screening Diagnosis Treatment Patient Information Education
Contact Us
New Patients
Initial Evaluation
Follow-up Plan
Nurse Navigator
Pre-Op Consult
Multidisciplinary Tumor Board
Pre-Op Instructions
Post-Op Instructions

As a result of P1 and P2 prevention trials sponsored by the NSABP we know that a woman’s risk of developing breast cancer can be reduced through preventive medications and a process called chemo prevention. The current available options for chemo prevention include Tamoxifen and its cousin Raloxifene (Evista). Tamoxifen blocks the effects of estrogen, a reproductive hormone that influences the growth and development of many breast cancers by binding to its receptor site. It can reduce a woman's risk of breast cancer by 30-50%. Raloxifene works in a similar way and reduces a woman’s risk of breast cancer by about 30%.  However, it is only prescribed to women who are postmenopausal.